Volt Carbon Technologies - Director, Zhongwei Chen.
Director, Zhongwei Chen.
Source: University of Waterloo.
  • Saint Jean Carbon (SJL) has announced a C$2.5M private placement with Sixty Two Capital
  • The company intends to use the proceeds for working capital and to further its battery technology development
  • Sixty Two Capital is an Australian-based investment and corporate advisory group focused on emerging companies in mining, technology and the life sciences
  • Saint Jean is a carbon science company focused on energy storage and green energy creation and re-creation
  • Saint Jean Carbon (SJL) is down by 10.34 per cent trading at $0.13 per share

Saint Jean Carbon (SJL) has announced a $2.5M private placement with Sixty Two Capital.

It will issue 20,000,000 units priced at $0.125.

Each unit is comprised of one common share and one-half of one common share purchase warrant.

Each warrant entitles the holder to purchase one additional share for $0.25 until January 31, 2024.

The company intends to use the proceeds for working capital and to further its battery technology development.

“We believe Saint Jean Carbon’s solid lithium battery development and graphite air-classification program will enable the company to establish itself as a leader in electrification technologies,” stated Sufian Ahmad, Director at Sixty Two Capital.

Sixty Two Capital is an Australian-based investment and corporate advisory group focused on emerging companies in mining, technology and the life sciences.

Saint Jean is a carbon science company focused on energy storage and green energy creation and re-creation.

Saint Jean Carbon (SJL) is down by 10.34 per cent trading at $0.13 per share as of 2:08 pm EST.

More From The Market Online

Westinghouse Electric files for US IPO

Westinghouse Electric Company, jointly owned by Cameco and Brookfield Renewable Partners, confidentially filed for a US IPO.

Buzz on the Bullboards: Contracts, cashflows, and delistings

Uncertainty around Iran has weighed on sentiment, reminding investors that even strong stories can be overshadowed by geopolitical risk.

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.